Arezoo Aghakhani
Overview
Explore the profile of Arezoo Aghakhani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
607
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alikhani M, Saberi S, Esmaeili M, Michel V, Tashakoripour M, Abdirad A, et al.
Iran Biomed J
. 2021 Aug;
25(5):323-33.
PMID: 34425651
Background: Variations in mitochondrial DNA copy number (mtDNA-CN) of peripheral blood leukocytes (PBLs), as a potential biomarker for gastric cancer (GC) screening has currently been subject to controversy. Herein, we...
2.
Aghasadeghi M, Aghakhani A, Mamishi S, Bidari-Zerehpoosh F, Haghi Ashtiani M, Sabeti S, et al.
Wien Med Wochenschr
. 2020 Apr;
170(9-10):218-223.
PMID: 32274600
Despite access to efficient hepatitis B virus (HBV) vaccine and universal immunization schedules, HBV infection remains a global health concern. HBV infection has decreased by this program. Nevertheless, breakthrough infections...
3.
Bavand A, Aghakhani A, Mohraz M, Banifazl M, Karami A, Golkar M, et al.
Iran J Pathol
. 2019 Sep;
14(1):68-75.
PMID: 31531103
Background & Objective: infection has public health importance and can lead to serious diseases in immunosuppressed patients, such as HIV cases. Appropriate control of infection in HIV patients requires information...
4.
Ramezani A, Baesi K, Banifazl M, Mohraz M, Khorvash F, Yaran M, et al.
Clin Res Hepatol Gastroenterol
. 2019 May;
43(5):594-602.
PMID: 31080115
Background: The introduction of direct acting antivirals (DAAs) for hepatitis C virus (HCV) treatment promises shorter treatment duration, higher cure rates and fewer side effects. Naturally, occurring Resistance Associated Substitutions...
5.
Ramezani A, Aghakhani A, Soleymani S, Bavand A, Bolhassani A
BMC Infect Dis
. 2019 Feb;
19(1):142.
PMID: 30755156
Background: Among different types of human papillomavirus (HPV), types 16 and 18 were known to be high-risk agents causing mainly cervical cancer. Up to now, the potential of HPV E7...
6.
Zadsar M, Aghakhani A, Banifazl M, Kazemimanesh M, Tabatabaei Yazdi S, Mamishi S, et al.
J Med Virol
. 2018 Apr;
90(8):1318-1322.
PMID: 29663448
Human parvovirus B19 (B19) infection is common among blood donors, and healthy blood donors can transmit virus via transfusion. Due to resistance of B19 to viral inactivation methods, there is...
7.
Sofian M, Banifazl M, Ziai M, Aghakhani A, Farazi A, Ramezani A
Iran J Pathol
. 2017 Sep;
11(4):328-333.
PMID: 28855924
Background: The household transmission of hepatitis B virus (HBV) is a major health problem. High incidence of HBV infection is observed within the household contacts of HBV carriers. We aimed...
8.
Mohraz M, Aghakhani A, Moayedi-Nia S, Banifazl M, Janbakhsh A, Mamishi S, et al.
Iran Biomed J
. 2017 Jul;
22(2):123-8.
PMID: 28688377
Background: Herpes simplex virus type 2 (HSV-2) is a common infection in human immunodeficiency virus (HIV) patients and may accelerate HIV progression by rising HIV viral load and decreasing CD4...
9.
Sofian M, Ramezani A, Imani H, Farazi A, Banifazl M, Jourabchi A, et al.
Iran J Microbiol
. 2017 Feb;
8(5):321-325.
PMID: 28149492
Background And Objectives: Hepatitis C virus (HCV) infection is a worldwide concern and it is the major cause of liver disease. Several genotypes of the HCV have been reported from...
10.
Sharif A, Aghakhani A, Velayati A, Banifazl M, Sharif M, Razeghi E, et al.
Intervirology
. 2017 Feb;
59(3):179-185.
PMID: 28142135
Objectives: The aim of this study was to evaluate the frequency and genotype of human parvovirus B19 and its relation with anemia among Iranian patients under dialysis. Methods: Fifty hemodialysis...